Hypokalemia may also occur. As with all sympathomimetic medications, cardiac arrest and even death may be associated with abuse of albuterol.
Treatment consists of discontinuation of albuterol together with appropriate symptomatic therapy.
The judicious use of a cardioselective beta-recptor blocker may be considered, bearing in mind that such medication can produce bronchospasm. There is insufficient evidence to determine if dialysis is beneficial for overdosage of albuterol. The inhalational median lethal dose has not been determined in animals. Dialysis is not appropriate treatment for overdosage of albuterol capsules for inhalation.